Novo to address concerns about misleading TV ad
Novo Nordisk confirmed receiving a notice from the U.S. Food and Drug Administration (FDA) regarding a TV advertisement for their newly launched Wegovy pill, which the FDA claims is “false or misleading.” The FDA argues the ad misleadingly suggests advantages over other weight loss drugs and implies emotional relief and psychological benefits. Novo Nordisk is […]